511509 — Vivo Bio Tech Cashflow Statement
0.000.00%
Last trade - 00:00- IN₹511.27m
- IN₹1.17bn
- IN₹533.35m
Annual cashflow statement for Vivo Bio Tech, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
C2022 March 31st | C2023 March 31st | 2024 March 31st | 2025 March 31st | 2026 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | Interim Report | ARS | ARS | PRESS |
| Standards: | IAS | IAS | IAS | IAS | — |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 44.7 | 46.2 | 40.6 | 87.9 | 48.1 |
| Depreciation | |||||
| Non-Cash Items | 39.9 | 76.5 | 77.8 | 28.9 | 57.9 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 7.3 | -142 | -56.1 | -88.7 | 136 |
| Change in Accounts Receivable | |||||
| Change in Accounts Payable | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 166 | 73.7 | 155 | 118 | 349 |
| Capital Expenditures | -511 | -40 | -79.5 | -223 | -374 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | — | — | — | 64.3 | -219 |
| Sale of Fixed Assets | |||||
| Purchase of Investments | |||||
| Cash from Investing Activities | -511 | -40 | -79.5 | -158 | -593 |
| Financing Cash Flow Items | -28.1 | — | -62.5 | -54.7 | -40.6 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 350 | -37.1 | -75.6 | 39 | 246 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 5.48 | -3.35 | 0.149 | -1.09 | 1.55 |